EPIC IMPACT BLOG

March 07,2019
2019 GU CANCER SYMPOSIUM WRAP: TARGETING ANTI-PSMA
The 2019 Genitourinary (GU) Cancers Symposium wrapped up with more than 4400 attendees gathered for talks, posters, and discussions centered on the management of GU malignancies. A plethora of new trial and study results were presented during the three-day scientific and educational meeting, with many focused on the androgen signaling pathway or optimizing existing chemotherapy use.
Read More